United States · Series C startup

Who invested in Prgnos

One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$21Mraised across 1 round since 2017, from 1 source

Latest round
Series C, $21MDec 2017
Investors
6
See who backed them

The rounds

  1. Dec 2017
    Series C$21M

    Reported by FinSMEs

Everyone who backed them

Hikma VenturesCorporate VC1round
CignaGrowth equity1round
GISm Hermedno record of our own yet1round
Maywicno record of our own yet1round
Safeguardno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Prgnos

Who invested in Prgnos?

Prgnos's investors include Merck Global Health Innovation Fund, Hikma Ventures, Cigna, GISm Hermed and Maywic, and 1 more on record.

How much has Prgnos raised?

Prgnos has raised $21M across 1 round since 2017.

When did Prgnos last raise?

Prgnos's most recent round was a Series C of $21M in Dec 2017.

What was Prgnos's biggest round?

Its most recent round, $21M in Dec 2017, is also its largest on record.

Who backed Prgnos first?

Prgnos's first round on record, in Dec 2017, was backed by Merck Global Health Innovation Fund, Hikma Ventures and Cigna and 3 others.

What stage is Prgnos at?

Prgnos's latest named round is a Series C, in Dec 2017.

Where is Prgnos based?

Prgnos is based in the United States.

Companies like Prgnos

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.